Requirements for B7-CD28 costimulation in mucosal IgA responses: Paradoxes observed in CTLA4-Hχ1 transgenic mice

Journal of Immunology

Volumn 161, Issue 1, 1998, Pages 49-59

  Gärdby, Eva ^a   Lane, Peter ^b   Lycke, Nils Y ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CHOLERA TOXIN; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; GERMINAL CENTER; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; LAMINA PROPRIA; LYMPHOID CELL; MALE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PERITONEAL CAVITY; PEYER PATCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; B-LYMPHOCYTE SUBSETS; CD4-POSITIVE T-LYMPHOCYTES; CHOLERA TOXIN; FEMALE; GASTRIC LAVAGE; HEMOCYANIN; HUMANS; IMMUNIZATION; IMMUNOCONJUGATES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN HEAVY CHAINS; INTESTINAL MUCOSA; LYMPHOID TISSUE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC;

EID: 0031858522     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Brandtzaeg, P. 1994. Distribution and characteristics of mucosal immunoglobulin-producing cells. In Handbook of Mucosal Immunology. L. Ogra, P., J. Mestecky, E. Lamm, M., W. Strober, J. McGhee, and J. Bienenstock, eds. Academic Press, San Diego, p. 251.
2. Strober, W., and R. Ehrhardt. 1994. Regulation of IgA B cell development. In Handbook of Mucosal Immunology. P. Ogra, W. Strober, J. Mestecky, J. McGhee, M. Lamm, and J. Bienenstock, eds. Academic Press, San Diego, p. 159.
3. Vajdy, M., M. Kosco-Vilbois, M. Kopf, G. Köhler, and N. Lycke. 1995. Impaired mucosal immune responses in interleukin 4-targeted mice. J. Exp. Med. 181:41.
4. Rousset, F., E. Gracia, and J. Banchereau. 1991. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J. Exp. Med. 173:705.
5. Dubois, B., B. Vanbervliet, J. Fayette, C. Massacrier, V. C. Kooten, F. Briere, J. Banchereau, and C. Caux. 1997. Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes. J. Exp. Med. 185:941.
6. Malisan, F., F. Briere, J.-M. Bridon, N. Harindranath, C. F. Mills, E. E. Max, J. Banchereau, and H. Martinez-Valdez. 1996. Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naive B lymphocytes. J. Exp. Med. 183:937.
7. Sparago, N., P. Zelazowski, L. Jin, T. M. McIntyre, E. Stuber, T. M. L. Pecanha, R. Kehry, M., J. Mond, J., E. E. Max, and M. C. Snapper. 1996. IL-10 selectively regulates murine Ig isotype switching. Int. Immunol. 8:781.
8. Ehrhardt, R., G. Harriman, J. Inman, N. Lycke, B. Gray, and W. Strober. 1996. Differential activation requirements of isotype switched B cells. Eur. J. Immunol. 26:1926.
9. Ehrhardt, R., B. Gray, R. Duchmann, J. Inman, and W. Strober. 1996. Reciprocal regulation of mucosal surface IgA+ B cells by Ig receptor cross-linking and CD40 ligand. J. Immunol. 157:1397.
10. + B cells by Ig receptor cross-linking and CD40 ligand. J. Immunol. 157:1397.
11. van Kooten, C., and J. Banchereau. 1997. Functions of CD40 on B cells, dendritic cells and other cells. Curr. Opin. Immunol. 9:330.
12. Wang, Z., G. J. Karras, G. R. Howard, and L. T. Rothstein. 1995. Induction of bcl-x by CD40 engagement rescues sIg-induced apoptosis in murine B cells. J. Immunol. 155:3722.
13. Gray, D., K. Siepmann, and G. Wohlleben. 1994. CD40 ligation in B cell activation, isotype switching and memory development. Semin. Immunol. 6:303.
14. Grewal, I. S., H. G. Foellmer, K. D. Grewal, J. Xu, F. Hadardottir, J. L. Baron, C. A. J. Janeway, and R. A. Flavell. 1996. Requirement for CD40 ligand in co-stimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 273:1864.
15. Yang, Y., and J. M. Wilson. 1996. CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science 273:1862.
16. Shinde, S., Y. Wu, Y. Guo, Q. Niu, J. Xu, S. I. Grewal, R. Flavell, and Y. Liu. 1996. CD40L is important for induction of, but not response to, costimulatory activity: ICAM-1 as the second costimulatory molecule rapidly up-regulated by CD40L. J. Immunol. 157:2764.
17. Kennedy, M. K., K. M. Mohler, K. D. Shanebeck, P. R. Baum, K. S. Picha, C. A. Otten-Evans, C. A. Janeway, and J. A. K. H. Grabstein. 1994. Induction of B cell stimulatory function by recombinant murine CD40L. Eur. J. Immunol. 24:116.
18. Ding, L., and E. Shevach. 1996. Activated B cells express CD28/B7-independent costimulatory activity. J. Immunol. 157:1389.
19. Essen, D., H. Kikutani, and D. Gray. 1995. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378:620.
20. Ding, L., M. J. Green, B. C. Thompson, and M. E. Shevach. 1995. B7/CD28-dependent and independent induction of CD40 ligand expression. J. Immunol. 155:5124.
21. Klaus, S. J., M. L. Pinchuk, D. H. Ochs, C.-L. Law, C. W. Fanslow, R. J. Armitage, and E. A. Clark. 1994. Costimulation through CD28 enhances T cell dependent B cell activation via CD40-CD40L interaction. J. Immunol. 152: 5643.
22. Rulifson, C. I., I. A. Sperling, E. P. Fields, W. F. Fitch, and A. J. Bluestone. 1997. CD28 costimulation promotes the production of Th2 cytokines. J. Immunol. 158: 658.
23. Subramanian, G., W. J. Kazura, E. Pearlman, X. Jia, I. Malhotra, and L. C. King. 1997. B7-2 requirement for Helminth-induced granuloma formation and CD4 type 2 T helper cell cytokine expression. J. Immunol. 158:5914.
24. Kuchroo, V., M. Das, J. Brown, A. Ranger, S. Zamvil, R. Sobel, H. Weiner, N. Nabavi, and L. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
25. Gause, W. C., S. J. Chen, R. J. Greenwald, M. J. Halvorson, P. Lu, X. D. Zhou, S. C. Morris, K. P. Lee, C. H. June, F. D. Finkelman, J. F. Urban, and R. Abe. 1997. CD28 dependence of T cell differentiation to IL-4 production varies with the particular type 2 immune response. J. Immunol. 158:4082.
26. Borriello, F., M. P. Sethna, S. D. Boyd, A. N. Schweizer, E. A. Tivol, D. Jacoby, T. B. Strom, E. M. Simpson, G. J. Freeman, and A. H. Sharpe. 1997. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6:303.
27. Maclennan, I. C. M., A. Gulbranson-Judge, K.-M. Toellner, M. Casamayor-Palleja, E. Chan, D. M.-Y. Sze, A. S. Luther, and H. A. Orbea. 1997. The changing preference of T and B cells for panners as T-dependent antibody responses develop. Immunol. Rev. 156:53.
28. Liu, Y. J., and J. Banchereau. 1996. The paths and molecular controls of peripheral B-cell development. Immunologist 4:55.
29. Ferguson, S., H. S. Kelsoe, and C. Thompson. 1996. CD28 is required for germinal center formation. J. Immunol. 156:4576.
30. Kawabe, T. 1994. The immune responses in CD40 deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1:167.
31. Foy, T. M., J. D. Laman, J. A. Ledbetter, A. Aruffo, E. Claassen, and R. Noelle. 1994. gp-39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180:157.
32. Han, S., K. Hathcock, B. Zheng, T. Kepler, R. Hodes, and G. Kelsoe. 1995. Cellular interaction in germinal centers: roles of CD40 ligand and B7-2 in established germinal centers. J. Immunol. 155:556.
33. Weinstein, P. D., and J. J. Cebra. 1991. The preference for switching to IgA expression by Peyer's patch germinal center B cells is likely due to the intrinsic influence of their microenvironment. J. Immunol. 147:4126.
34. Cebra, J., and K. Shroff. 1994. Peyer's patches as inductive sites for IgA commitment. In Handbook of Mucosal Immunology. P. Ogra, W. Strober, J. Mestecky, J. McGhee, M. Lamm, and J. Bienenstock, eds. Academic Press, San Diego, p. 151.
35. Kroese, M. G. F., B. A. Kantor, and A. L. Herzenberg. 1994. The role of B-1 cells in mucosal immune responses. In Handbook of Mucosal Immunology. L. Pearay, O., J. Mestecky, M. Lamm, E., W. Strober, R. McGhee, and J. Bienenstock, eds. Academic Press, San Diego, p. 217.
36. Cebra, J. J., P. J. Gearhart, J. F. Halsey, J. L. Hurwitz, and R. D. Shahin. 1980. Role of environmental antigens in the ontogeny of the secretory immune response. J. Reticuloendothel. Soc. 28:61.
37. Butcher, E. C. R. V., R. L. Rouse, C. N. Nottenberg, R. R. Hardy, and I. Weissman. 1982. Surface phenotype of Peyer's patch germinal centers: implications for the role of germinal centers in B cell differentiation. J. Immunol. 129:2698.
38. Kosco-Vilbois, M. H., H. Zentgraf, J. Gerdes, and J.-Y. Bonnefoy. 1997. To∼'B' or not to 'B' a germinal center? Immunol. Today 18:225.
39. Hörnquist, E., L. Ekman, D. Grdic, K. Schön, and N. Lycke. 1995. Paradoxical IgA immunity in CD4-deficient mice: lack of cholera toxin specific protective immunity despite normal gut mucosal IgA differentiation. J. Immunol. 155:2877.
40. + T-cells and defective antibody production in vivo. J. Exp. Med. 179:809.
41. + T cells. J. Exp. Med. 179:819.
42. Chambers, C. A., and J. P. Allison. 1997. Co-stimulation in T cell responses. Curr. Opin. Immunol. 9:396.
43. + T cell dependent. Infect. Immun. 59:3630.
44. Lycke, N., and L. Lefrancois. 1996. Isolation of mouse small intestinal intraepithelial lymphocytes, Peyer's patch and lamina propria. In Current Protocols in Immunology, Vol. 1. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley & Sons, Washington, D.C., p. 3.19.1.
45. Lycke, N. Y., and R. Coico. 1996. Measurement of immunoglobulin synthesis using the ELISPOT assay. In Current Protocols in Immunology, Vol. 2. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley & Sons, Washington, D.C., p. 7.14.1.
46. Elson, C., O. W. Ealding, and J. Lefkowitz. 1984. A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. J. Immunol. Methods 67:101.
47. Hörnquist, E., and N. Lycke. 1993. Cholera toxin adjuvant greatly promotes antigen priming by T cells. Eur. J. Immunol. 23:2136.
48. Murakami, M., T. Tsubata, R. Shinkura, S. Nisitani, M. Okamoto, H. Yoshioka, T. Usui, S. Miyawaki, and T. Honjo. 1994. Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse. J. Exp. Med. 180:111.
49. Pecquet, S. S., C. Ehrat, and P. B. Ernst. 1992. Enhancement of mucosal antibody responses to salmonella typhimurium and the microbial hapten phosphorylcholine in mice with X-linked immunodeficiency by B-cell precursors from the peritoneal cavity. Infect. Immun. 60:503.
50. Beagley, K., A. Murray, J. McGhee, and J. Eldridge. 1995. Peritoneal cavity CD5 (B1a) B cells: cytokine induced IgA secretion and homing to intestinal lamina propria in SCID mice. Immunol. Cell Biol. 73:425.
51. Kroese, F. G. M., E. C. Butcher, A. M. Stall, and L. A. Herzenberg. 1989. A major peritoneal reservoir of precursors for intestinal IgA plasma cells. Immunol. Invest. 18:47.
52. Lycke, N. 1993. Cholera toxin promotes B cell isotype switching by two different mechanisms. J. Immunol. 150:4810.
53. Lycke, N., A. K. Bromander, L. Ekman, D. Grdic, E. Hömquist, M. Kjerrulf, M. Kopf, M. Kosco-Vilbois, K. Schön, and M. Vajdy. 1995. The use of knockout mice in studies of induction and regulation of gut mucosal immunity. Mucosal Immunol. Update 3:1.
54. Xu-Amano, J., H. Kiyono, R. Jackson, H. F. Stats, K. Fujihashi, P. D. Burrows, C. O. Elson, S. Pillai, and J. R. McGhee. 1993. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 178:1309.
55. Greenwald, R. J., P. Lu, J. M. Halvorson, X.-d. Zhou, S.-j. Chen, B. K. Madden, J. P. Perrin, C. S. Morris, D. F. Finkelman, R. Peach, S. P. Linsley, F. J. Urban, and J. A. W. C. Cause. 1997. Effects of blocking B7-1 and B7-2 interactions during a type 2 in vivo immune response. J. Immunol. 158:4088.
56. Lycke, N. 1996. A molecular approach to the construction of an effective mucosal vaccine adjuvant: studies based on cholera toxin ADP-ribosylalion and cell targeting. In Essentials of Mucosal Immunology. M. F. Kagnoff and H. Kiyono, eds. Academic Press, San Diego, p. 563.
57. Neutra, M. R., and J.-P. Kraehenbuhl. 1992. Transepithelial transport and mucosal defence. I. The role of M cells. Trends Cell. Biol. 2:134.
58. Wang, D., S. M. Wells, A. M. Stall, and A. E. Kabat. 1994. Reactions of germinal centers in the T-cell-independent response to the bacterial polysaccharide a(1-6)dextran. Proc. Natl. Acad. Sci. USA 91:2502.
59. Gottstein, B., P. Deplazes, and I. Tanner. 1993. In vitro synthesized immunoglobulin A from nul+ and reconstituted nu/nu mice against a dominant surface antigen of Giardia lamblia. Parasitol. Res. 79:644.
60. Dianda, L., A. Gulbranson-Judge, W. Pao, A. Hayday, I. MacLennan, and M. Owen. 1996. Germinal center formation in mice lacking αβ T cells. Eur. J. Immunol. 26:1603.
61. Noel, J. P., H. L. Boise, M. J. Green, and C. B. Thompson. 1996. CD28 costimulation prevents cell death during primary T cell activation. J. Immunol. 157:636.
62. Boise, H. L., J. A. Minn, J. P. Noel, H. C. June, A. M. Accavitti, T. Lindsten, and B. C. Thompson. 1995. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XI. Immunity 3:87.
63. Lu, L., S. Qian, A. P. Hershberger, A. W. Rudert, H. D. Lynch, and W. A. Thomson. 1997. Fas ligand (CD95) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J. Immunol. 158:5676.
64. Singer, G. G., and A. K. Abbas. 1994. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365.
65. Klas, C., K. M. Debatin, R. R. Jonker, and P. H. Krammer. 1993. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5:625.
66. Elson, C. O., and M. T. Dertzbaugh. 1994. Mucosal adjuvants. In Handbook of Mucosal Immunology. P. L. Ogra, J. Mestecky, M. E. Lamm, W. Strober, J. R. McGhee, and J. Bienenstock, eds. Academic Press, San Diego, p. 391.
67. Ågren, L. C., L. Ekman, L. Löwenadler, and N. Y. Lycke. 1997. Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit. J. Immunol. 158:3936.
68. Guèry, J.-C., F. Ria, F. Galbiati, and L. Adorini. 1997. Normal B cells fail to secrete interleukin-12. Eur. J. Immunol. 27:1632.
69. Stack, R. M., D. J. Lenschow, G. S. Gray, J. A. Bluestone, and F. W. Fitch. 1994. IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2. J. Immunol. 152:5723.
70. Gause, W. C., M. J. Halvorson, P. Lu, R. Greenwald, P. Linsley, J. F. Urban, and F. D. Finkelman. 1997. The function of costimulatory molecules and the development of IL-4-producing T cells. Immunol. Today 18:115.
71. Bromander, A., J. Holmgren, and N. Lycke. 1991. Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro. J. Immunol. 146:2908.